… Hubaux, School of Computer and Communication Sciences, Ecole Polytechnique Federale
de Lausanne; email: jeanpierre.hubaux@epfl.ch; J. Fellay, School of Life Sciences, Ecole …

Understanding why some people establish and maintain effective control of HIV-1 and
others do not is a priority in the effort to develop new treatments for HIV/AIDS. Using a whole-…

Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and
is an important cause of liver-related morbidity and mortality 1 . The standard of care therapy …

Over the past four decades, research on the natural history of HIV infection has described
how HIV wreaks havoc on human immunity and causes AIDS. HIV host genomic research, …

Chronic infection with hepatitis C virus (HCV) affects 170 million people worldwide and is
the leading cause of cirrhosis in North America 1 . Although the recommended treatment for …

Background The importance of sex and gender as modulators of disease biology and treatment
outcomes is well known in other disciplines of medicine, such as cardiology, but remains …

… J Fellay, CB Eap, and A Telenti designed the study. C Marzolini and LA Decosterd measured
drug … The report was written by J Fellay and A Telenti, with contributions from all co-authors. …

INTRODUCTION Clinical outcomes of human severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection range from silent infection to lethal coronavirus disease 2019 (…

To extend the understanding of host genetic determinants of HIV-1 control, we performed a
genome-wide association study in a cohort of 2,554 infected Caucasian subjects. The study …

… J Fellay and A Telenti wrote the report, assisted by all coauthors. … antiretroviral treatment:
Swiss HIV Cohort Study—In this article by J Fellay and colleagues (Oct 20, p 1322), there was …